A Look At Taylor Morrison Home (TMHC) Valuation After Renewed Analyst Optimism On Earnings And Backlog

Taylor Morrison Home Corporation

Taylor Morrison Home Corporation

TMHC

0.00

Analysts have recently renewed their positive views on Taylor Morrison Home (TMHC) after the homebuilder reported strong earnings, a growing sold backlog, and lower unsold inventory, drawing attention to the stock once again.

The recent analyst interest comes as the stock shows mixed momentum, with a 7 day share price return of 2.42% but a 90 day share price return that fell 9.65%. However, the 5 year total shareholder return of 101.68% points to stronger longer term results overall.

If this mix of short term swings and long term compounding has your attention, now could be a good moment to broaden your watchlist and check out 19 top founder-led companies

With TMHC trading at US$60 against an average analyst price target of about US$70, and with recent revenue and net income declines, the key question is whether there is genuine value on offer or whether markets are already pricing in future growth.

Most Popular Narrative: 14.4% Undervalued

At a last close of $60 versus a narrative fair value near $70, Taylor Morrison Home is framed as modestly undervalued, with the story hinging on how margins and growth hold up.

The company's current backlog is down ~30% year-over-year and order activity (net orders) is down 12%, reflecting softening buyer demand despite favorable demographic trends. If this persists, future revenues and earnings growth could fall short of expectations even as current deliveries are supported by high spec inventory.

Curious what sits behind that valuation gap, the narrative leans heavily on changing revenue trends, thinner margins, and a future earnings multiple that assumes investors will pay up. The key is how those ingredients interact over time.

Result: Fair Value of $70.11 (UNDERVALUED)

However, there are also clear risks, including softer buyer demand and a higher spec mix, that could pressure margins and challenge the idea that TMHC is meaningfully undervalued.

Another View: DCF Suggests Limited Upside

While the analyst narrative points to a fair value around $70 per share, the SWS DCF model paints a stricter picture, with an estimated future cash flow value of about $42.87. That gap suggests the story looks very different depending on which lens you trust more.

For investors, the key question is whether earnings quality and buybacks outweigh the weaker DCF output, or whether the cash flow view is a useful warning sign about how much risk you are taking at $60.

TMHC Discounted Cash Flow as at May 2026
TMHC Discounted Cash Flow as at May 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Taylor Morrison Home for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 50 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Given this mix of enthusiasm and caution around TMHC, it can help to review the key numbers yourself and decide where you stand. To see how the balance of potential upside and downside looks when laid out side by side, take a closer look at the 2 key rewards and 1 important warning sign.

Looking for more investment ideas?

If TMHC has sharpened your focus, do not stop here. Broaden your opportunity set now so you are not relying on a single stock story.

  • Target potential mispricings by scanning 50 high quality undervalued stocks that combine quality fundamentals with attractive entry points.
  • Strengthen your income stream by reviewing 12 dividend fortresses that pair higher yields with a focus on resilience.
  • Get ahead of the crowd by checking the screener containing 21 high quality undiscovered gems before other investors start paying attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.